The Use of Intraoperative Radiolymphoscintigraphy for Sentinel Node Biopsy in Patients with Malignant Melanoma

background Selective lymphadenectomy or “sentinel node” biopsy Ms been introduced recently by Morton and colleagues (Arch Surg 1992;127:392–9) to stage patients with intermediate and thick malignant melanomas. It has proven to be an effective way to identify nodal basins at risk for metastasis without the morbidity of a complete lymph node dissection. The majority of biopsies can be performed under local anesthesia with small incisions, but technical difficulties occasionally result in unsuccessful explorations. Identification of the sentinel node can be enhanced by a intraoperative radiolymphoscintigraphy, a technique introduced Alex and Krag (Surg Oncol 1993;137–43) tint uses radiolabeled sulfur colloid and a hand‐held gamma probe. objective We used intraoperative radiolymphoscintigraphy in conjunction with 1% lymphazurin blue dye to define the sentinel node(s) in 148 patients with greater than 0.76 mm in thickness or Clark level TV melanomas. Sentinel lymph nodes were isolated, harvested, and examined using conventional histopathology, and immunohistochemistry for S‐100 and HMB‐45 antibodies. results The overall success rate of sentinel lymph node localization was 97% using a combination of the two techniques. Twenty‐one (34%) patients had micrometastasis, and 17 of these subsequently underwent complete lymph node dissection. A total of 220 of 275 (80%) sentinel nodes harvested were radioactive or “hot” compared with 165 of 275 (60%) with the blue dye alone. Four of the patients with micrometastasis had sentinel nodes positive by gamma probe, but negative by blue dye mapping techniques. conclusion Our results suggest that intraoperative radiolymphosintigraphy using a hand‐held gamma detecting probe improves the identification of sentinel lymph nodes during selective lymphadenectomy. This may reduce the number of “unsuccessful explorations” using the vital blue dye technique for lymphatic mapping, and appeal to a greater variety of surgeons, including dermatologic surgeons.

[1]  F. Sim,et al.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. , 1986, Mayo Clinic proceedings.

[2]  D. Reintgen,et al.  Recurrent malignant melanoma: the identification of prognostic factors to predict survival. , 1992, Annals of plastic surgery.

[3]  R. Clark,et al.  Lymphoscintigraphy in malignant melanoma. , 1992, Annals of plastic surgery.

[4]  C. Balch,et al.  Three unresolved issues in the surgical treatment of melanoma. , 1988, Oncology.

[5]  D. Reintgen,et al.  The concept of lymph node dissections in patients with malignant melanoma. , 1992, Annals of plastic surgery.

[6]  M. Ross,et al.  The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.

[7]  N. J. Crowley.  The Case Against Elective Lymphadenectomy , 1992 .

[8]  D. Reintgen,et al.  Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. , 1983, Annals of surgery.

[9]  R. Elashoff,et al.  Improved Long-term Survival After Lymphadenectomy of Melanoma Metastatic to Regional Nodes , 1991 .

[10]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[11]  D. Weaver,et al.  Gamma-probe-guided lymph node localization in malignant melanoma. , 1993, Surgical oncology.

[12]  M. Ross,et al.  Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. , 1993, Seminars in surgical oncology.

[13]  M. Cuesta,et al.  Gamma probe‐guided sentinel node biopsy to select patients with melanoma for lymphadenectomy , 1994, The British journal of surgery.

[14]  F. Sim,et al.  A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results , 1978, Cancer.

[15]  D. Reintgen,et al.  The Role of Selective Lymphadenectomy in the Management of Patients with Malignant Melanoma , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[16]  M. Ross.  The Case for Elective Lymphadenectomy , 1992 .

[17]  N. Cascinelli,et al.  Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. , 1977, The New England journal of medicine.

[18]  D. Morton,et al.  Lymphatic drainage of skin to a sentinel lymph node in a feline model. , 1991, Annals of surgery.

[19]  Field Rj.  Beyond the scalpel. , 1995 .

[20]  C. Balch.  The role of elective lymph node dissection in melanoma: rationale, results, and controversies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C. Balch,et al.  Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients , 1982, The British journal of surgery.

[22]  R. Clark,et al.  Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. , 1991, American journal of surgery.

[23]  D. Krag,et al.  Gamma-probe guided localization of lymph nodes. , 1993, Surgical oncology.

[24]  C. Balch.  Surgical management of regional lymph nodes in cutaneous melanoma. , 1980, Journal of the American Academy of Dermatology.

[25]  C. Seiler,et al.  Recovery from bilateral vocal cord paralysis following thyroid surgery , 1994, The British journal of surgery.

[26]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: III. Prognostic Factors in Melanoma Patients with Lymph Node Metastases (Stage II) , 1981, Annals of surgery.

[27]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.